HONG KONG, Oct. 27, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited (“Golden Meditech” or the “Company,” -- 801.HK; 910801.TW), today announces that the Group’s Chairman, Mr. KAM Yuen, and his family have purchased 53,828,000 shares of the Company from the open market on the disclosure date (October 27, 2011), at the average price of HK$0.85 per share via a representative holding company, as per disclosure to the Hong Kong Exchanges and Clearings Limited. As a result of which, Mr. Kam and family have increased their interest in the Company from 19.01% to 21.64%.
Mr. Kam is the founder of the Company and is currently serving as the Group’s Chairman and Chief Executive Officer. Mr. Kam has over twenty years of experience in healthcare industry in China. Under his helm, the Group has grown from a single product medical devices producer to a leading healthcare enterprise in China and a leader in multiple markets, including medical devices, hospital management and cord blood banking.
About Golden Meditech Holdings Limited
Golden Meditech Holdings Limited is China‘s leading integrated-healthcare enterprise and a first-mover in the industry. Over the years, the Group has established dominant positions in different market segments including medical devices and healthcare-related services in umbilical cord blood banking and hospital operation, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China‘s healthcare industry both through organic growth and strategic expansion.
For enquiries, please contact:
Investor Relations Department
Golden Meditech Holdings Limited
Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong
Tel: +852-3605-8180
Fax: +852-3605-8181
Email: ir@goldenmeditech.com
SOURCE Golden Meditech Holdings Limited
